Navidea Biopharmaceuticals Competitors and Similar CompaniesClear all
Navidea Biopharmaceuticals's competitors and similar companies include Proteus Digital Health, Adaptive Biotechnologies, ALK-Abello and Artms.
 Navidea Biopharmaceuticals Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. |  Proteus Digital Health Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics. |  Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. |  Artms Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope. | ||
Founding Date | Founding Date 1983 | Founding Date 2001 | Founding Date 2009 | Founding Date 1923 | Founding Date 2013 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Dublin, US HQ Thame, GB | Locations Redwood City, US HQ Hayward, US | Locations Seattle, US HQ New York, US South San Francisco, US | Locations Hørsholm, DK HQ | Locations Burnaby, CA HQ |
Employees | Employees 137% decrease | Employees 632% increase | Employees 70910% decrease | Employees 2,736 | Employees 283% decrease |
Valuation ($) | Valuation ($) 100.1 k | Valuation ($) 1.6 b | Valuation ($) 694.6 m | Valuation ($) 6.1 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $65.7k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $277m (FY, 2025) | Revenue (est.) kr6.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.9k (FY, 2022) | Cost of goods N/A | Cost of goods $71.4m (FY, 2025) | Cost of goods kr1.8b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ($119.3k) (FY, 2022) | Gross profit N/A | Gross profit $205.6m (FY, 2025) | Gross profit kr4.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($15.2m) (FY, 2022) | Net income N/A | Net income ($59.5m) (FY, 2025) | Net income kr1.2b (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 88m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 19m (about 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 517m | Total funding raised $ 525m | Total funding raised N/A | Total funding raised $ 22m |
For sources of this data, please see the company profile
View Company Profiles
Proteus Digital Health
HQ
Redwood City, US
Employees
63↑ 2% increase
Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics.
View companyAdaptive Biotechnologies
HQ
Seattle, US
Employees
709↓ 10% decrease
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View company
ALK-Abello
HQ
Hørsholm, DK
Employees
2,736
Alk Abello A/S is a Denmark-based company active within the pharmaceutical industry.
View companyArtms
HQ
Burnaby, CA
Employees
28↓ 3% decrease
Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope.
View company